Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.570
0.00 (0.00%)
At close: Apr 3, 2025, 4:00 PM
2.508
-0.062 (-2.41%)
Pre-market: Apr 4, 2025, 4:00 AM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $15.14 million as of April 3, 2025. Its market cap has increased by 184.10% in one year.
Market Cap
15.14M
Enterprise Value
10.39M
1-Year Change
184.10%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $15.14M, a decrease of -85.38%. That is a compound annual growth rate of -35.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 15.14M | -40.09% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.59B |
| UnitedHealth Group | 494.35B |
| Johnson & Johnson | 385.14B |
| AbbVie | 356.70B |
| Novo Nordisk | 300.62B |
| AstraZeneca | 231.80B |
| Abbott Laboratories | 228.29B |
| Merck & Co. | 218.22B |